Ipca Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 to consider and approve Standalone and Consolidated Unaudited Financial Results for the 3rd quarter and nine months ended 31st December, 2025.
The above information is a part of company’s filings submitted to BSE.